ConductScience.org, home

Trial · NCT01133353

A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome

NCT01133353, Phase 2, Withdrawn, Bausch Health Americas, Inc.

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome. Trials, record NCT01133353. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01133353

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
A Study of the Effectiveness and Safety of Tetrabenazine MR in Pediatric Subjects With Tourette's Syndrome
NCT number
NCT01133353
Status
Withdrawn
Phases
Phase 2
Enrollment
0 participants, actual
Lead sponsor
Bausch Health Americas, Inc.
Conditions
Tourette's Syndrome
Interventions
Tetrabenazine MR, Placebo
First posted
2010-05-28
Last updated
2019-11-29

Source ClinicalTrials.gov

Registered outcomes7

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryImprovement in total tic score as measured by the Yale Global Tic Severity Score (YGTSS)Days 0 to 84
SecondaryTo evaluate the safety and tolerability of tetrabenazine using cognitive measuresDays 0 and 84
SecondaryTo evaluate the safety and tolerability of tetrabenazine using an assessment of depressionDays 0 to 84
SecondaryTo evaluate the safety and tolerability of tetrabenazine using an assessment of suicidalityDays 0 to 91
SecondaryTo explore the therapeutic effects of tetrabenazine using the full YGTSSDays 0 to 84
SecondaryTo explore the therapeutic effects of tetrabenazine using the Patient Global Impression of Change scale (PGI-C)Days 0 to 84
SecondaryTo explore the therapeutic effects of tetrabenazine using the Clinical Global Impression of Severity scale (CGI-S)Days 0 to 84

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01133353

GET https://conductscience.org/api/trials/v1/NCT01133353/registered